Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules…

Overview of attention for article published in Lancet Infectious Diseases, June 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

news: 1 news outlet
policy: 1 policy source

twitter: 8 X users

Readers on

mendeley: 58 Mendeley

So far, Altmetric has seen 11 X posts from 8 X users, with an upper bound of 84,596 followers.

RT @cre_ichear: So proud to be @MenziesResearch and to receive this award for PREVIX-VOICES study aiming to improve use of vaccines to redu…

So proud to be @MenziesResearch and to receive this award for PREVIX-VOICES study aiming to improve use of vaccines to reduce ear disease and hearing loss in First Nations children @OMOZ2024 #earhealthforlife @KelvinKongENT https://t.co/OerVHEVxyk

RT @amandajleach: AddThis | Home https://t.co/hUxJsFjoBE Novel combined schedules of different pneumococcal conjugate vaccines show import…

RT @TheLancetInfDis: New Research: Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent o…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 7 additional X posts.